drugset / Trial / NCT04599478
Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
Phase 2/3
Active not recruiting
160 enrolled
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will compare the effectiveness of behavioral and pharmacologic treatments, alone and in combination, for the treatment of loss-of-control eating and weight following bariatric surgery. This is an acute treatment comparing behavioral weight loss alone or in combination with combination naltrexone/bupropion medication.
Timeline
- Start
- 2021-06-29
- Primary completion
- 2025-12-12
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | — | Oral |
| Subject | Naltrexone | Small molecule | — | Oral |